Single Lab Test

5-Hydroxyindoleacetic Acid (HIAA), Quantitative, Random Urine (Pediatric)

Back to Search
Categories
Organ System
:
Nervous system
Clinical Conditions
:
Serotonin Secreting Tumors
Turnaround Time
4 - 8 days
CPT Code
8,257,083,497
Test Type

1 mL aliquotUrine (random)

Overview

A serotonin analysis is most frequently performed for the diagnosis of carcinoid tumors of the enterochromaffin (Kultschitzsky) cells of the small intestine. These tumor cells release large amounts of serotonin, which can produce the clinical syndrome of flushing, diarrhea, and right-sided heart failure. The most frequently used diagnostic test for carcinoid tumors is 5-HIAA, the final metabolite of serotonin. Diagnose carcinoid tumors and syndrome; values >25 mg/24 hours (higher if the patient has malabsorption) are strong evidence for carcinoid.

5-HIAA may be normal with nonmetastatic carcinoid tumor and may be normal even with the carcinoid syndrome, particularly in subjects without diarrhea. Some patients with the carcinoid syndrome excrete nonhydroxylated indolic acids, not measured as 5-HIAA.2 Midgut carcinoids are most apt to produce the carcinoid syndrome with 5-HIAA elevation. Patients with renal disease may have falsely low 5-HIAA levels in the urine.3 5-HIAA is increased in untreated patients with malabsorption, who have increased urinary tryptophan metabolites. Such patients include those with celiac disease, tropical sprue, Whipple disease, stasis syndrome, and cystic fibrosis. It is increased in those with chronic intestinal obstruction.4 Poor correlation exists between 5-HIAA level and the clinical severity of the carcinoid syndrome.4 Recent studies confirm its use as a prognostic factor in this disease.5

This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration.

1. Soldin SJ, Brugnara C, Gunter KC, eds. Pediatric Reference Ranges. 2nd ed. Washington, DC: AACC Press;1997:89.

2. Johnson HC Jr. Urine tests. In: Berk JE, ed. Bockus Gastroenterology. 4th ed, vol 1. Philadelphia, Pa: WB Saunders Co;1985:342-347.

3. Schultz AL. 5-Hydroxyindoleacetic acid. In: Pesce AJ, Kaplan LA, eds.Methods in Clinical Chemistry. St Louis, Mo: Mosby-Year Book Inc;1987:714-720.

4. Warner RR. Carcinoid tumor. In: Berk JE, ed, Bockus Gastroenterology. 4th ed, vol 3. Philadelphia, Pa: WB Saunders Co; 1985:1874-1876.

5. Agranovich AL, Anderson GH, Manji M, et al. Carcinoid tumour of the gastrointestinal tract: Prognostic factors and disease outcome. J Surg Oncol. 1991; 47(1):45-52. PubMed 1708841

6. Feldman JM. Urinary serotonin in the diagnosis of carcinoid tumors. Clin Chem. 1986; 32(5):840-844. PubMed 2421946

Collection Details

Patient Preparation:

Avoid bananas, avocados, plums, eggplant, tomatoes, avocados plums, eggplant, tomatoes, plantain, pineapple, walnuts, and interfering drugs for a 72 hour period prior to and during collection. Foods and medications associated with altered urinary HIAA results: Decreased HIAA: Aspirin, chlorpromazine (Thorazine), corticotropin, dihydroxyphenylacetic acid, alcohol, gentisic acid, homogentisic acid, hydrazine derivatives, imipramine (Tofranil®), <isocarboxazid (Marplan), keto acids, levodopa, MAO inhibitors, methenamine methyldopa (Aldomet®), perchlorperazine, phenothiazines (Compazine®), promazine, promethazine (Mepergan®). Increased HIAA: Acetaminophen, acetanilide, caffeine, coumaric acid, diazepam (Valium®), ephedrine, fluorouracil glycerol guaiacolate (Guaifenesin), melphalan (Alkeran®), mephenesin, methamphetamine (Desoxyn), methocarbamol (Robaxin®), naproxen, nicotine, phenacetin, phenmetrazine, phenobarbital, phentolamine, rauwolfia, reserpine.

Collection Instructions:

Discover the Evexia advantage

Start Ordering Today

Take advantage of all the time and money-saving features that Evexia Diagnostics has to offer. Simply click the button below to get started.